Paper90689
Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease?
Schleusener H and 5 others. J Endocrinol Invest, 1978. Cited by 25 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease? Papers, record 90689. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/90689
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease?
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antithyroid Agents | Major topic |
| Graves Disease | Major topic |
| Immunoglobulin G | Major topic |
| Humans | |
| Radioligand Assay | |
| Recurrence | |
| Thyroid Function Tests | |
| Thyrotropin |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,368,451 | Binding of thyroid stimulators to thyroid membranes. | FEBS Lett | 1974 | https://conductscience.org/library/papers/4368451 | PubMed |
| 2 | 821,961 | Thyroid-stimulating immunoglobulins and the control of thyroid function. | J Clin Endocrinol Metab | 1976 | https://conductscience.org/library/papers/821961 | PubMed |
| 3 | 1,242,809 | Long-acting thyroid stimulator and related factors. | Proc R Soc Med | 1975 | https://conductscience.org/library/papers/1242809 | PubMed |
| 4 | 69,269 | Short-term antithyroid drug therapy for the thyrotoxicosis of Graves's disease. | N Engl J Med | 1977 | https://conductscience.org/library/papers/69269 | PubMed |
| 5 | 4,823,927 | Evidence of lower toxicity during thyroxine suppression after a single 3-mg L-thyroxine dose: comparison to the classical L-triiodothyronine test for thyroid suppressibility. | J Clin Endocrinol Metab | 1974 | https://conductscience.org/library/papers/4823927 | PubMed |
| 6 | 4,801,124 | Sequential assessment during drug treatment of thyrotoxicosis. | Clin Endocrinol (Oxf) | 1973 | https://conductscience.org/library/papers/4801124 | PubMed |
| 7 | 4,432,950 | Quantitative thyroid scanning: a reliable thyroid function test. | Am J Roentgenol Radium Ther Nucl Med | 1974 | https://conductscience.org/library/papers/4432950 | PubMed |
| 8 | 68,278 | Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease. | Lancet | 1977 | https://conductscience.org/library/papers/68278 | PubMed |
| 9 | 4,601,273 | The pathogenesis of Graves' disease and Hashimoto's thyroiditis. | Clin Endocrinol (Oxf) | 1974 | https://conductscience.org/library/papers/4601273 | PubMed |
| 10 | 47,482 | Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. | Lancet | 1975 | https://conductscience.org/library/papers/47482 | PubMed |
| 11 | 5,109,861 | Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders. | J Clin Endocrinol Metab | 1971 | https://conductscience.org/library/papers/5109861 | PubMed |
| 12 | 50,946 | [Controlled therapy of hyperthyroidism]. | Ergeb Inn Med Kinderheilkd | 1975 | https://conductscience.org/library/papers/50946 | PubMed |
| 13 | 4,212,870 | [TRH stimulation test with age and sex specific TSH response in normal subjects (authors' transl)]. | Klin Wochenschr | 1974 | https://conductscience.org/library/papers/4212870 | PubMed |
| 15 | 4,406,686 | Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis. | Br Med J | 1974 | https://conductscience.org/library/papers/4406686 | PubMed |
| 16 | 177,449 | A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves' disease. | J Clin Endocrinol Metab | 1976 | https://conductscience.org/library/papers/177449 | PubMed |
| 17 | 576,175 | Identification of subgroups of euthyroid graves's ophthalmopathy. | N Engl J Med | 1977 | https://conductscience.org/library/papers/576175 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,896,520 | Changes of circulating thyroid autoantibody levels during and after the therapy with methimazole in patients with Graves' disease. | J Endocrinol Invest | 1982 | https://conductscience.org/library/papers/6896520 | PubMed |
| 6,147,377 | 10 years experience with consecutive measurement of thyrotropin binding inhibiting antibodies (TBIAb). | J Endocrinol Invest | 1984 | https://conductscience.org/library/papers/6147377 | PubMed |
| 6,139,399 | The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment. | J Endocrinol Invest | 1983 | https://conductscience.org/library/papers/6139399 | PubMed |
| 2,879,958 | Thyroid-stimulating antibodies in patients with long-term remission of Graves' hyperthyroidism. | Klin Wochenschr | 1986 | https://conductscience.org/library/papers/2879958 | PubMed |
| 2,868,149 | Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease. | Klin Wochenschr | 1985 | https://conductscience.org/library/papers/2868149 | PubMed |
| 2,573,625 | Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves' disease within one year. | J Endocrinol Invest | 1989 | https://conductscience.org/library/papers/2573625 | PubMed |
| 2,421,862 | Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease. | CMAJ | 1986 | https://conductscience.org/library/papers/2421862 | PubMed |
| 1,357,830 | Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease. | World J Surg | 1992 | https://conductscience.org/library/papers/1357830 | PubMed |
| 582,828 | Interference of thyroglobulin in TSab detection by radio-receptor assay. | J Endocrinol Invest | 1979 | https://conductscience.org/library/papers/582828 | PubMed |
| 581,653 | Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis. | Br Med J | 1979 | https://conductscience.org/library/papers/581653 | PubMed |
| 381,768 | [Cell receptor defects as the cause of endocrine and metabolic diseases (author's transl)]. | Klin Wochenschr | 1979 | https://conductscience.org/library/papers/381768 | PubMed |
| 227,717 | TSH-receptor antibodies, HLA B8 and thyroid autoantibodies in patients with Graves' disease in therapeutically induced euthyroidism. | Experientia | 1979 | https://conductscience.org/library/papers/227717 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/90689
GET https://conductscience.org/api/papers/v1/90689/authors